Position in ZVRA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$11,111,879
+$736,982 QoQ
Shares Held
1,192,262
+3.0% QoQ
Ownership
2.02%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 96.21484203975301.ToString("F0")%
Shared 0.ToString("F0")%
None 3.7851579602469925.ToString("F0")%
Common Shares in ZVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. ZVRA ranks #126 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in ZVRA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,111,879 | 1,192,262 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $10,374,897 | 1,157,913 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $5,287,081 | 555,950 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $1,877,302 | 213,088 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $1,586,738 | 211,848 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,145,237 | 257,223 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $884,729 | 127,483 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $306,928 | 62,639 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $522,733 | 90,127 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $485,635 | 74,143 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $134,527 | 27,911 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $262,394 | 51,450 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $265,023 | 48,186 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $48,056 | 10,470 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $109,885 | 17,610 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $247,858 | 55,574 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $72,289 | 14,372 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $143,015 | 16,420 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $407,252 | 43,650 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $272,217 | 21,234 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $92,855 | 10,093 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||